Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$0.546
-0.0197 (-3.48%)
At Close: May 09, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.537 $0.770 Thursday, 9th May 2024 ATRA stock ended at $0.546. This is 3.48% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 7.95% from a day low at $0.537 to a day high of $0.580.
90 days $0.537 $0.94
52 weeks $0.199 $2.54

Historical Atara Biotherapeutics prices

Date Open High Low Close Volume
Jul 06, 2016 $22.33 $23.28 $22.27 $22.93 177 600
Jul 05, 2016 $22.54 $22.87 $22.31 $22.51 170 100
Jul 01, 2016 $22.49 $22.90 $22.18 $22.80 299 300
Jun 30, 2016 $22.51 $22.66 $22.04 $22.51 244 900
Jun 29, 2016 $22.81 $23.25 $22.19 $22.51 262 600
Jun 28, 2016 $21.32 $22.34 $20.87 $22.15 246 600
Jun 27, 2016 $21.07 $21.48 $19.92 $20.78 330 400
Jun 24, 2016 $20.75 $21.94 $20.04 $21.48 1 386 100
Jun 23, 2016 $21.85 $22.42 $20.85 $22.06 504 800
Jun 22, 2016 $21.55 $22.69 $20.88 $21.93 595 500
Jun 21, 2016 $21.23 $21.66 $20.90 $21.56 448 200
Jun 20, 2016 $20.02 $21.37 $19.79 $21.06 164 100
Jun 17, 2016 $20.77 $21.29 $19.78 $19.85 269 200
Jun 16, 2016 $19.91 $20.77 $19.46 $20.70 95 143
Jun 15, 2016 $19.75 $20.37 $19.56 $20.11 143 184
Jun 14, 2016 $19.82 $20.09 $18.86 $19.53 211 795
Jun 13, 2016 $19.24 $20.18 $19.24 $19.88 168 393
Jun 10, 2016 $19.73 $20.33 $19.21 $19.53 183 171
Jun 09, 2016 $20.46 $20.75 $19.83 $20.10 170 062
Jun 08, 2016 $21.07 $21.16 $20.02 $20.73 182 516
Jun 07, 2016 $19.45 $21.25 $18.62 $20.99 322 805
Jun 06, 2016 $18.32 $19.87 $17.64 $19.35 160 631
Jun 03, 2016 $18.99 $19.08 $17.56 $18.17 131 650
Jun 02, 2016 $18.03 $19.20 $17.95 $19.13 203 569
Jun 01, 2016 $18.02 $18.25 $17.60 $18.09 99 308
Click to get the best stock tips daily for free!

About Atara Biotherapeutics

Atara Biotherapeutics Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company i... ATRA Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT